Good morning, everybody, and welcome to a different working week. We hope the weekend respite was stress-free and invigorating, as a result of that oh-so-familiar routine of conferences, deadlines, and messages has returned. However what are you able to do? There is no such thing as a pause button to cease the world, similar to it’s, from spinning. So this implies one factor: time to dig in to the duties at hand. On that be aware, we’ve got assembled a menu of tidbits that can assist you get began. In the meantime, we’ve got additionally fired up the espresso kettle for one more cup of stimulation. Our selection at the moment is Mexican cinnamon. We hope your day is just smashing and, as at all times, do be in contact if one thing saucy arises …
Sarepta Therapeutics is halting shipments of its Duchenne muscular dystrophy gene remedy for sufferers who can not stroll, following the demise of a second one that acquired the therapy, STAT writes. The corporate disclosed the primary affected person demise — a 16-year-old boy — in March. Each occurred from acute liver failure, a facet impact that has been seen with different gene therapies. Sarepta mentioned each sufferers have been non-ambulatory, which means their illness had progressed to the purpose they relied on a wheelchair. Most youngsters with Duchenne lose the power to stroll by adolescence. The corporate is now working with specialists to provide you with an enhanced immunosuppressive routine that would make the remedy, referred to as Elevidys, safer for non-ambulatory sufferers. Sarepta additionally mentioned it was pausing dosing in an ongoing medical trial of Elevidys, referred to as Envision, that’s centered on older ambulatory and non-ambulatory sufferers.
Sens. Bernie Sanders (I-Vt.) and Angus King (I-Maine) launched a invoice that may ban pharmaceutical producers from utilizing direct-to-consumer promoting, together with social media, to advertise their merchandise, The Wall Road Journal writes. The invoice would prohibit any promotional communications concentrating on customers, together with by tv, radio, print, digital platforms, and social media. It would apply to all prescription drug commercials. The invoice comes after repeated calls from Division of Well being and Human Companies Secretary Robert F. Kennedy Jr. to finish prescription drug promoting. Kennedy mentioned whereas operating for president that he would problem an govt order kicking pharmaceutical commercials off tv, arguing that Individuals take too many prescription medicines and suggesting that trade spending was influencing information protection of the drug trade. Sanders and King every voted towards Kennedy’s affirmation, however are critics of prescription drug adverts. King in February launched a invoice to ban pharmaceutical promoting to customers within the first three years after a medication’s approval, following different efforts in previous years.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
